• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Nemaura Medical touts precision data for non-invasive glucose monitor

December 6, 2017 By Sarah Faulkner

NemauraNemaura Medical (OTC:NMRD) touted precision data today from the on-going European clinical trial program of its non-invasive, needle-free glucose monitoring system, sugarBeat.

The study included 16 patients with Type I and Type II diabetes. The participants wore two sugarBeat skin-patches simultaneously over 3 days for up to 14 hours each day.

The trial showed that more than 80% of the data between the two skin-patches at each time point were within 8% of each other.

Results from the precision trial provide concrete validation of the sugarBeat system, the company said.

“The precision study for sugarBeat has exceeded our expectations and is a significant milestone towards commercial launch,” CEO Faz Chowdhury said in prepared remarks.

Nemaura’s on-going clinical trial program in Europe is slated to finish later this month and the company said it hopes to launch sugarBeat in the U.K. in early 2018.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Clinical Trials, Diabetes, Featured, Patient Monitoring, Research & Development, Wall Street Beat Tagged With: Nemaura Medical

IN CASE YOU MISSED IT

  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS